← Weight Management
Most EffectiveNot a controlled substanceWritten to your own pharmacy
Zepbound® / Mounjaro® (tirzepatide)
FDA-approved dual GLP-1/GIP agonist
Manufacturer-produced tirzepatide, the dual GLP-1 and GIP agonist with the strongest published weight-loss outcomes. Prescribed to your pharmacy with full benefits navigation.
Regulatory status
FDA-approved finished drug product.
Frequency
Weekly injection
Route
Subcutaneous
Supply
Filled at your pharmacy
Minimum age
18+
What it does
What patients get from this
- Highest average weight reduction of any approved agent
- Dual incretin mechanism
- Coverage and savings-card navigation included
- Self-pay pharmacy programmes sourced where coverage fails
We will not prescribe this if
- Personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2
- Current pregnancy or breastfeeding
- History of pancreatitis
The intake asks about each of these. Some answers stop the process; others are flagged for your nurse practitioner.
Labs your NP may order
- CMP
- HbA1c
- Lipid panel
- TSH
Draw at our Fort Lauderdale clinic or a reference lab near you. Your NP reviews the results and posts them to your account.
Please read
- Medication is billed by your pharmacy and your insurer, not by VitalisRx. Your membership covers the clinical care.